In vitro osteoblastic response to 30 vol% hydroxyapatite-polyethylene composite

Area of Science:

• Biomaterials Science
• Orthopedic Research
• Tissue Engineering

Background:

• Hydroxyapatite-reinforced high-density polyethylene (HA-HDPE) composite is a clinically established bone replacement material for middle ear prostheses and orbital floor implants.
• Further clinical applications are being explored, necessitating detailed biocompatibility assessments for novel uses such as skull reconstruction.

Purpose of the Study:

• To evaluate the in vitro biocompatibility of HA-HDPE composite for potential application as skull reconstruction implants.
• To compare the biological response of human osteoblast cells from different anatomical sites (femoral heads and crania) on HA-HDPE composites.

Main Methods:

• In vitro assessment using human osteoblast cells isolated from femoral heads and crania.
• Evaluation of HA-HDPE composites (30 vol %) with two grades of hydroxyapatite (HA) filler exhibiting different surface morphologies (smooth vs. rough).

Main Results:

• HA-HDPE composite demonstrated bioactivity, supporting osteoblast attachment, proliferation, and differentiation.
• Composites with rough-surfaced HA filler exhibited a slightly superior cellular response compared to those with smooth-surfaced HA filler.
• Osteoblastic cells from cranial bone showed a generally slower response than those from femoral heads.

Conclusions:

• The in vitro results indicate that HA-HDPE composite is a promising candidate for skull reconstruction implants.
• The surface morphology of the HA filler influences cellular response, with rougher surfaces being more favorable.
• Further investigation into the cranial osteoblast response is warranted, but the material shows significant potential.